Frexalimab, CAS 2515463-86-0

Product Description: Frexalimab (SAR441344; INX-021) is a monoclonal antibody targeting the CD40 ligand (CD40L). Frexalimab has the potential for multiple sclerosis research[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Bruce A C Cree, et al. New drugs for multiple sclerosis: new treatment algorithms. Curr Opin Neurol. 2022 Jun 1;35(3):262-270.

CAS Number: 2515463-86-0

Molecular Weight: N/A

Compound Purity: 98.33

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: TNF Receptor

• Artikelnummer: MEXHY-P99625-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99625-1
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated